ARTISS a Single-centre Randomised Control Study

• Status: Not yet recruiting
• Trial end date: 2022-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

The Influence of ARTISS on post-operative abdominal drainage and seroma formation in DIEP/MS-TRAM free flap breast reconstruction patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mid and South Essex NHS Foundation Trust
• Treatments: Fibrin Tissue Adhesive; Thrombin

Criteria

Inclusion Criteria:

• Female adult (age 18-80)

• Patients planned for immediate or delayed DIEP/MS-TRAM breast reconstruction

Exclusion Criteria:

• Patients who are unable to consent or do not consent

• Clotting disorder

• Pregnancy

• Individuals whose immune system is depressed or who have some types of anaemia (e.g. sickle cell disease or haemolytic anaemia).

• COVID positive

• Known previous allergic reactions to ARTISS